• Increasing immunotherapy efficacy of anti PD-L1 (No. T4-2059)

    Immunotherapy has revolutionized cancer treatment by activating the immune system to attack tumor cells. However, notable limitations remain, including differential responses between individuals and cancer types. Dr. ... Read more
    Prof Rony Dahan

    Rony Dahan

    Faculty of Biology

  • Peptides for Treating Alzheimer's Disease (No. T4-2057)

    Alzheimer's Disease (AD) is an age-associated neurodegenerative disorder characterized clinically by a decline in cognitive function. It is the most common type of dementia, with 5.8 million Americans living with AS in 2020. ... Read more
    Full Professor Ruth Arnon

    Ruth Arnon

    Faculty of Biology

  • Covalent Chemistry Platform for Diagnostics and Drug Discovery (No. T4-2045)

    delivery and activation of drugs or probes is of great importance in therapeutics, diagnostics, and research. For instance, selective delivery/activation of anti-cancer drugs to tumor cells is crucial for their efficacy and reduced side effects. ... Read more
    Senior Scientist Nir London

    Nir London

    Faculty of Chemistry

  • Treating Chronic Pain by Inhibiting Importin Alpha 3 (No. T4-2040)

    Pain, particularly in cases of chronic nerve injury and disease, is a critical element of numerous medical conditions and procedures, which is generally managed with opioid analgesics. ... Read more
    Full Professor Michael Fainzilber

    Michael Fainzilber

    Faculty of Biochemistry

  • Safer CAR-T cell platform (No. T4-2033)

    Chimeric Antigen Receptor (CAR)-T Cell Therapy is a personalized treatment for cancer in which the patient's T cells are genetically engineered to express a synthetic receptor that binds a tumor antigen. ... Read more
    Associate Professor Sarel FLEISHMAN

    Sarel-Jacob Fleishman

    Faculty of Biochemistry

  • A Platform for Boosting Efficiency of Therapeutic RNA Editing (No. T4-2028)

    Single-point mutations can give rise to a wide spectrum of genetic diseases. Recent therapeutic approaches aim at editing the mutated mRNA, providing a safe, reversible and tunable treatment. ... Read more
    Senior Scientist Schraga Schwartz

    Schraga Schwartz

    Faculty of Biochemistry

  • Biologic Drug for prevention and treatment of COVID-19 (No. T4-2024)

    Combat against COVID-19 is still ongoing worldwide. ... Read more
    Full Professor Yinon Rudich

    Yinon Rudich

    Faculty of Chemistry

  • Biologic Drug for prevention and treatment of COVID-19 (No. T4-2024)

    Combat against COVID-19 is still ongoing worldwide. ... Read more
    Full Professor Gideon Schreiber

    Gideon Schreiber

    Faculty of Biochemistry

  • Small Molecules for Treatment of Huntington's Disease and Related Disorders (No. T4-1947)

    Trinucleotide repeats expansion disorders (TREDs) are a set of diseases in which repetitions of short DNA segments (three nucleotides) occur and accumulate in the genome. ... Read more
    Full Professor Rivka Dikstein

    Rivka Dikstein

    Faculty of Biochemistry

  • Microbiome Therapeutic for Treating Bacterial Vaginosis (No. T4-1945)

    Treating bacterial vaginosis by performing vaginal microbial transplants (VMT). ... Read more
    Associate Professor Eran Elinav

    Eran Elinav

    Faculty of Biology



Subscribe to Pharmaceuticals